Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach

Mohamed Abd El-Aziz 0001, Yasmine S. Moemen, Aboul Ella Hassanien, Shengwu Xiong. Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach. Appl. Soft Comput., 97(Part):105509, 2020. [doi]

Abstract

Abstract is missing.